Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1058 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-02-26 (hospitalmanagement.net)
SGH and Charles River team up for CGMP cell banking services
Singapore General Hospital (SGH) has entered into an agreement with Charles River Laboratories to advance cancer treatment.
Read more
2025-02-25 (stocktitan.net)
Charles River Partners With Singapore Hospital For Cell Therapy Manufacturing Services | CRL Stock News
Charles River will provide CGMP cell banking and NGS services to Singapore General Hospital, supporting allogeneic CAR-T cell production for cancer clinical trials.
Read more
2025-02-17 (boersen-zeitung.de)
"Simcorp is a long-term industry Bet by Deutsche Börse" |
Former Simcorp CEO Christian Kromann moved up to the Deutsche Börse Executive Board in January, where he oversees Investment Management Solutions. In an interview, he talks about his vision for the strategically important business division.
Read more
2025-02-11 (businesswire.com)
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions | Business Wire
Charles River and Deciphex focus on advancing image management solutions, while developing novel AI tools for toxicologic pathology.
Read more
2025-02-11 (stocktitan.net)
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
Charles River Labs partners with Deciphex to enhance toxicologic pathology with AI-powered solutions, streamlining drug safety assessment workflows globally.
Read more
2025-02-10 (stocktitan.net)
Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
Hoth Therapeutics teams with OnTargetx R&D for important immunohistochemistry study of HT-KIT, targeting c-Kit receptors in cancer treatment advancement.
Read more
2025-02-10 (lexpress.mu)
Singe traffic: Stop Monkey Massacre opposes an agreement with Charles River Laboratories
The Stop Monkey Massacre platform sent a letter to Prime Minister, Navin Ramgoolam, and to the Minister of Agroindustrie, Arvin Boolell, to request to cancel the signing of a memorandum of understanding (*Memorandum of Understanding*) with. ..
Read more
2025-01-17 (newstarget.com)
Dr. Bryan Ardis BLOWS THE WHISTLE on COVID-19 and CLOT SHOTS attacking the body like snake venom and he speaks on detoxification and prevention of damage
Dr. Bryan Ardis, with his Global Healings Team, has identified natural remedies to protect against the effects of COVID-19 and “clot shot” spike protein injections. The team, drawing from indigenous medicine and global natural resources, has sourced plants and minerals that can detoxify and protect against foreign particles and prions. Some recommended remedies include organic […]
Read more
2025-01-17 (pharmasource.global)
Charles River Integrates Akron Bio’s CGMP Cytokines into Cell Therapy Flex Platform -
Charles River Laboratories International and Akron Bio, a supplier of advanced therapy materials, have announced a partnership to integrate Akron’s Closed System Solutions (CSS) line…
Read more